Table 2.
Summary of outcomes.
| First author (year) | Sample diagnosis |
Mean sessions completed, %a | Primary outcome | Improvementb | ||
| Over time | Greater than comparison |
Maintained at follow-up |
||||
| Gardner-Nix (2008) [34] | Chronic pain | Unclear | Quality of life—physical health | No | No | N/Ac |
| Quality of life—mental health | Yes | Yesd | N/A | |||
| Pain catastrophizing | Yes | Yesd | N/A | |||
| Usual pain | Yes | Yesd | N/A | |||
| Buhrman (2013) [29] | Chronic pain | 60 | Pain acceptance | Yes | Yes | Yes (6 moe) |
| Davis (2013) [33] | Fibromyalgia | 69 | Pain | No | No | N/A |
| Pain coping efficacy | Yes | Yes | N/A | |||
| Positive affect | Yes | Yes | N/A | |||
| Negative affect | Yes | No | N/A | |||
| Social engagement | Yes | Yes | N/A | |||
| Loneliness | Yes | Yes | N/A | |||
| Family stress | Yes | No | N/A | |||
| Family enjoyment | Yes | Yes | N/A | |||
| Stress coping efficacy | Yes | Yes | N/A | |||
| Dowd (2015) [30] | Chronic pain | 94f | Pain interference | Yes | No | Yes (6 mo) |
| Psychological distress | No | No | No (6 mo) | |||
| Trompetter (2015) [31] | Chronic pain | Unclear | Pain interference | Yes | Nog | Nog (6 mo) |
| Younge (2015) [35] | Heart disease | Unclear | Exercise capacity | Yes | Marginally (P=.05) | N/A |
| Ljótsson (2010) [36] | IBSh | Unclear | IBS symptoms | Yes | Yes | N/A |
| IBS symptom severity | Yes | Yes | Yes (3 mo) | |||
| Ljótsson (2011) [38] | IBS | Unclear | IBS symptom severity | Yes | Yes | Yes (6 mo) |
| Ljótsson (2011) [39] | IBS | Unclear | IBS symptom severity | Yes | Yes | Yes (12 mo) |
| Ljótsson (2014) [40] | IBS | Unclear | IBS symptom severity | Yes | Yes | Yes (6 mo) |
| Thompson (2010) [41] | Epilepsy | 75i | Depressive symptoms | Yes | Yes | N/A |
| Thompson (2015) [42] | Epilepsy | 83 | Depressive symptoms | Yes | Yes | Yes (4.5-5 mo) |
| Hesser (2012) [43] | Tinnitus | Unclear | Tinnitus distress severity | Yes | Yesd | Yes (12 mo) |
| Johansson (2015) [44] | Acquired brain injury | Unclear | Mental fatigue | Yes | Yes | N/A |
| Zernicke (2014) [45] | Cancer | 67 | Feasibility | N/A | N/A | N/A |
| Bruggeman-Everts (2015) [47] | Cancer | 70 | Fatigue severity | Yes | N/A | N/A |
aMean intervention completion refers to the mean % of modules the participants participated in.
bImprovement—Over time and Improvement—Greater than comparison refer to postintervention assessments.
cN/A: not applicable.
dGreater than wait-list control but not greater than on-site comparison group.
emo: months.
fOf those who completed follow-up.
gGreater than active comparison group but not wait-list control.
hIBS: irritable bowel syndrome.
iMedian reported.